Print PDF


Healthcare Reform Calls for Proactive IP Portfolios

Medical Design
October 2009

Raciti, Eric P.


In this article, Finnegan partner Eric Raciti discusses the importance of proactive IP portfolios for medical-device companies facing increases in pricing pressure and competition due to healthcare reform. The authors argue that, with or without healthcare reform, the most competitive medical-device manufacturers will be those that develop innovative products, distinguish themselves from their competitors’ offerings, and maintain a competitive advantage through a strategic IP portfolio. Raciti and McAnulty explain that being smart about patent portfolio management can help companies reduce costs and also maximize value, and conclude that medical-device companies should be proactive with respect to their patent portfolio by prioritizing developments, focusing resources on high-value patents and applications, and evaluate the total-cycle costs associated with developing and maintaining a patent portfolio.